Britain approves Pfizer's antiviral COVID-19 pill
Dec 31 (Reuters) - Britain has approved Pfizer's (PFE.N) COVID-19 pill for adults who have mild to moderate infection and are at high risk of their illness worsening, its second easily administered antiviral against the coronavirus. Britain is scrambling to build its defences amid a record surge in COVID-19 cases in the winter season as the Omicron variant of the virus spreads quickly. Based on data, the pill, Paxlovid, is most effective when taken during the early stages of COVID-19, ...
阅读更多